CompaniesIONETIX

IONETIX

active

Lansing, MI, United States

Founded 2010

About

Radiopharmaceutical

Areas of Focus

Categories

DiagnosticsRadiopharmaceuticalsMidwest

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

200

By Phase

NA: 1

By Status

UNKNOWN: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2021

2022

2023

2024

2025

Today

Hover over trial bars to see details

Recent Trials

NCT05433974Collaborator

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

200 participants

Started: Oct 1, 2022 · Completed: Jun 1, 2024

Funding History (5)

D

Aug 26, 2024

D/A

May 6, 2020

D

Dec 21, 2018

D/A

Mar 12, 2018

D

Apr 27, 2016

Locations (1)

Headquarters

Lansing, MI, United States

Map

Loading map...